INTERCEPT PHARMACEUTICALS, INC. short interest in 2021
In 2021, INTERCEPT PHARMACEUTICALS, INC.'s disclosed short interest ran from 21.58% of shares outstanding on 15 Jan 2021 to 28.46% on 31 Dec 2021, a change of +6.88 percentage points. The year's high was 29.10% on 15 Dec 2021 and its low 14.91% on 15 Jul 2021, averaging 22.25% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.99 days on 29 Oct 2021. Full history: INTERCEPT PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2021 in figures
- Start of year
- 21.58% (15 Jan 2021)
- End of year
- 28.46% (31 Dec 2021)
- Change
- +6.88 pp
- High
- 29.10% (15 Dec 2021)
- Low
- 14.91% (15 Jul 2021)
- Average
- 22.25%
- Highest days to cover
- 15.99 (29 Oct 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 21.58% | 5.90 | |
| 29 Jan 2021 | 21.09% | 6.18 | |
| 12 Feb 2021 | 18.26% | 10.35 | |
| 26 Feb 2021 | 19.40% | 7.28 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 21.94% | 6.51 | |
| 31 Mar 2021 | 22.65% | 7.73 | |
| 15 Apr 2021 | 22.66% | 8.62 | |
| 30 Apr 2021 | 19.45% | 5.41 | |
| 14 May 2021 | 18.85% | 6.88 | 10-Q filed, results (8-K) |
| 28 May 2021 | 18.26% | 5.34 | |
| 15 Jun 2021 | 17.23% | 7.12 | |
| 30 Jun 2021 | 15.24% | 7.96 | |
| 15 Jul 2021 | 14.91% | 10.85 | |
| 30 Jul 2021 | 15.28% | 10.25 | 10-Q filed, results (8-K) |
| 13 Aug 2021 | 25.60% | 5.80 | |
| 31 Aug 2021 | 23.20% | 6.42 | |
| 15 Sep 2021 | 25.59% | 9.49 | |
| 30 Sep 2021 | 26.88% | 10.27 | |
| 15 Oct 2021 | 26.19% | 12.18 | |
| 29 Oct 2021 | 25.49% | 15.99 | |
| 15 Nov 2021 | 28.33% | 6.48 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 28.24% | 12.29 | |
| 15 Dec 2021 | 29.10% | 8.09 | |
| 31 Dec 2021 | 28.46% | 9.64 |
See also: INTERCEPT PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.